Showing 21-25 of 93 predictive & prescriptive analytics:
What Health IT Trend Has You Most Excited?

Healthcare IT Today February 28, 2024 Read the full article >> Burnout is something that can slowly creep up on you but take a long time to crawl out of. This serious problem is something that happens with you are overworked and overstressed from the problems you are tasked with at work. In the world[…]

AI Identifies Clinical Phenotypes of Rapid Fibrosis Progression in MASH

Gastroenterology Advisor Jessica Nye, PhD January 25, 2024 Read the full release >> Key Point: Although a proof-of-concept study, the findings illustrate AI’s potential for creating phenotypic representations of real-world data that can help identify rapid fibrosis progression in MASH. Detailed real-world data from organ systems may be used to stratify patient risk for rapid[…]

OM1 to Present Research on Multiple Sclerosis at ACTRIMS Forum 2024

Dr. Carl Marci to present on utilizing real-world data for multiple sclerosis research to improve understanding and treatment of the disease February 27, 2024 09:00 AM Eastern Standard Time –(BUSINESS WIRE)–OM1: WHAT: OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, today announced an upcoming poster presentation hosted by Dr.[…]

Rare Disease Detection With AI: What Tools to Trust

Dermatology Times February 20, 2024 Read the full article >> “Rare Disease Day raises awareness for the 300 million people living with rare diseases around the world and their families and carers. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis and [delayed] treatment,” writes the Rare Disease Day organization.1 Rare Disease Day has[…]

AI and Digital Phenotyping for Clinical Development

Wed, Jan 31, 2024 2:00 PM – 3:00 PM EST Register here >> With the new year comes even more hype with how AI will transform the healthcare and pharmaceutical landscape – including McKinsey estimating that AI technology could generate up to $110 billion a year in economic value for the pharma and medical-product industries.[…]

1 3 4 5 6 7 19